Mackenzie Financial Corp Increases Stake in Avantor, Inc. (NYSE:AVTR)

Mackenzie Financial Corp increased its position in Avantor, Inc. (NYSE:AVTR) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 46,610 shares of the company’s stock after buying an additional 747 shares during the quarter. Mackenzie Financial Corp’s holdings in Avantor were worth $1,064,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Raymond James & Associates raised its stake in shares of Avantor by 84.8% in the 4th quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock valued at $26,612,000 after acquiring an additional 534,901 shares during the period. DAVENPORT & Co LLC lifted its stake in shares of Avantor by 17.6% during the fourth quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock worth $52,430,000 after purchasing an additional 342,452 shares in the last quarter. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Avantor by 8.4% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock worth $57,269,000 after purchasing an additional 194,031 shares in the last quarter. Northern Trust Corp boosted its position in shares of Avantor by 9.0% in the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock worth $87,049,000 after buying an additional 342,553 shares during the period. Finally, State Board of Administration of Florida Retirement System lifted its position in Avantor by 12.7% during the 3rd quarter. State Board of Administration of Florida Retirement System now owns 658,563 shares of the company’s stock worth $13,883,000 after acquiring an additional 74,078 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Down 0.7 %

Shares of NYSE:AVTR opened at $25.46 on Thursday. The company has a 50 day moving average of $25.05 and a 200-day moving average of $22.57. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The firm has a market cap of $17.27 billion, a P/E ratio of 53.04, a P/E/G ratio of 2.48 and a beta of 1.37. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $26.16.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.70 billion. During the same period in the prior year, the firm posted $0.32 earnings per share. The firm’s revenue for the quarter was down 4.0% compared to the same quarter last year. As a group, analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Insider Buying and Selling at Avantor

In related news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the sale, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

AVTR has been the topic of a number of recent research reports. Royal Bank of Canada boosted their target price on shares of Avantor from $28.00 to $29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. boosted their price target on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. Deutsche Bank Aktiengesellschaft lifted their price target on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, April 18th. Robert W. Baird upped their price target on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. Finally, Evercore ISI lifted their price objective on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.